
Cycad Group
Description
Cycad Group is a venture capital firm based in Santa Barbara, California, specializing in equity investments in early to intermediate stage technology companies. Established with a focus on supporting innovative tech ventures, the firm operates with a relatively private profile. Its primary known fund, Cycad Group Fund I, L.P., was established in 2018 with a total capital commitment of $10 million. This fund size suggests a strategy focused on a concentrated portfolio, likely involving a mix of initial investments and follow-on capital for promising portfolio companies.
The firm's investment philosophy targets companies poised for significant growth within the technology sector. While public information on their most recent investment activities is limited, their historical portfolio includes notable companies such as AppFolio (APPF) and Procore (PCOR), both of which have achieved substantial market presence. These investments highlight Cycad Group's capacity to identify and back companies that can scale effectively, potentially indicating a preference for business models with clear paths to market leadership.
Given the $10 million fund size and their stated interest in early to intermediate stage companies, Cycad Group's typical initial check sizes would likely fall within a specific range. For a fund of this scale, initial investments often range from approximately $500,000 to $2,000,000, allowing for participation in multiple rounds and reserving capital for follow-on opportunities. The firm's limited public presence, including a "coming soon" website and a lack of recent public investment announcements since 2019, suggests a highly selective or private investment approach, or that the 2018 fund is largely deployed.
Investor Profile
Cycad Group has backed more than 26 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 8% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Typical check size: $500K – $2M.
Stage Focus
- Series B (31%)
- Series C (19%)
- Series A (19%)
- Series Unknown (12%)
- Series D (8%)
- Private Equity (4%)
- Post Ipo Equity (4%)
- Grant (4%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Health Diagnostics
- Manufacturing
- Clinical Trials
- Pharmaceutical
- Automotive
- Therapeutics
- Advanced Materials
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.